Fernando J. Martínez

University of Massachusetts Chan Medical School — United States

Medicine · Health Sciences

156h-index136.0kcitations1.3kworks5.22yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Chronic Obstructive Pulmonary Disease (COPD) Research(697), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis(357), Respiratory Support and Mechanisms(249), Asthma and respiratory diseases(245), Inhalation and Respiratory Drug Delivery(121)

Publications1.3k total

Age-dependent Genetic Risk in Pulmonary Fibrosis Patients and Relatives
2026Open Access
Switch-like methylation of functional pathways distinguishes COPD and idiopathic pulmonary fibrosis
2025Open Access
Epigenomic study of the lower airway reveals COPD-associated methylation patterns and potential microbiota links
BMJ Open Respiratory Research·2025Open Access
Frequent productive cough in COPD relates to exacerbation risk and treatment benefit from budesonide/glycopyrrolate/formoterol fumarate: a post hoc analysis of KRONOS
Respiratory Medicine·2025Open Access
The number needed to treat with dupilumab to prevent moderate or severe chronic obstructive pulmonary disease exacerbations: BOREAS and NOTUS
2025
Late Breaking Abstract - Effect of nerandomilast on clinical outcomes in patients with progressive pulmonary fibrosis (PPF): results from the final database lock of the FIBRONEER-ILD trial
2025
Initiation of supplemental oxygen in the FIBRONEER-IPF trial of nerandomilast in patients with idiopathic pulmonary fibrosis
2025
Effect of add-on dupilumab in elderly patients with chronic obstructive pulmonary disease: BOREAS and NOTUS
2025
Effect of nerandomilast in subgroups of patients with idiopathic pulmonary fibrosis (IPF) in the FIBRONEER-IPF trial
2025
Late Breaking Abstract - Effect of nerandomilast on clinical outcomes in patients with idiopathic pulmonary fibrosis (IPF): data from final database lock of the FIBRONEER-IPF trial
2025
Relationship between improvement in lung function and patient-reported outcomes in chronic obstructive pulmonary disease with dupilumab treatment: causal mediation analyses
2025
Late Breaking Abstract - Safety and tolerability of nerandomilast in patients with pulmonary fibrosis: pooled data from the FIBRONEER-IPF and FIBRONEER-ILD trials
2025
Watching an Evolution in Progress, Cutting-Edge Research Transforming Outcomes in Interstitial Lung Disease: Introduction to an <i>AJRCCM</i> Special Section
American Journal of Respiratory and Critical Care Medicine·2025Open Access
Neutrophil-to-Lymphocyte Ratio as a Biomarker in Clinically Stable Chronic Obstructive Pulmonary Disease: SPIROMICS Cohort
Annals of the American Thoracic Society·2025· 4 citedOpen Access
Safety of budesonide/glycopyrronium/formoterol fumarate dihydrate delivered by HFO-1234ze versus HFA-134a in chronic obstructive pulmonary disease: a phase 3, multi-site, randomised, double-blind, parallel-group, active-comparator study
EClinicalMedicine·2025· 1 citedOpen Access
Stackelberg Coupling of Online Representation Learning and Reinforcement Learning
arXiv (Cornell University)·2025Open Access
Characterizing COPD Symptom Variability in the Stable State Utilizing the Evaluating Respiratory Symptoms in COPD Instrument.
UNC Libraries·2025· 1 citedOpen Access
Mucus Plugs and Emphysema in the Pathophysiology of Airflow Obstruction and Hypoxemia in Smokers.
UNC Libraries·2025Open Access
Airway mucin MUC5AC and MUC5B concentrations and the initiation and progression of chronic obstructive pulmonary disease: an analysis of the SPIROMICS cohort
UNC Libraries·2025Open Access
Reversible Airflow Obstruction Predicts Future Chronic Obstructive Pulmonary Disease Development in the SPIROMICS Cohort: An Observational Cohort Study.
UNC Libraries·2025Open Access
page 1 of 64Next →

Frequent Co-authors

Ganesh Raghu(11), Athol U. Wells(11), Bartolomé R. Celli(11), Gerard J. Criner(11), Àlvar Agustí(10), Antonio Anzueto(10), MeiLan K. Han(10), Jørgen Vestbo(9), Claus Vogelmeier(9), Peter J. Barnes(9), Robert A. Stockley(9), David Halpin(9), Dave Singh(9), Leonardo M. Fabbri(8), Harold R. Collard(8), Kevin M. Brown(8), Don D. Sin(7), Thomas V. Colby(7), Luca Richeldi(7), Moisés Selman(7)